Citigroup provided a stock rating for Altimmune, Inc.
1 report, 1 independent
Updated Sep 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup provided a stock rating for Altimmune, Inc.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Altimmune, Inc.
American biopharmaceutical company
Nothing else this week.
Related events
- Citigroup restated a buy rating on shares while Societe Generale Group was noted as a France-based group.
- Citigroup reiterated a positive rating on BioPharma on October 7, 2026.
- Citigroup reaffirmed a market outperform rating for HealthEquity.
- Citigroup reiterated a market outperform rating for Alphabet Inc.
- Privia Health Group, Inc. shares are listed on the Nasdaq exchange, and Citigroup reissued a buy rating on the stock.